​Riekelt Houtkooper

Riekelt Houtkooper is a full professor of Translational Metabolism, principal investigator at Laboratory Genetic Metabolic Diseases at Amsterdam UMC, location AMC of the University of Amsterdam Amsterdam, The Netherlands.          

Riekelt Houtkooper received his PhD from the Laboratory Genetic Metabolic Diseases of the Amsterdam UMC-AMC. His research centered on cardiolipin metabolism, particularly in relation to the rare mitochondrial disorder Barth syndrome. During a postdoctoral project in Lausanne (CH) geared towards understanding and treating more common metabolic diseases, he became interested in the metabolic aspects of aging. Early 2012 Riekelt moved back to Amsterdam to start his own research group, for which he received funding from NWO and the ERC. Current research in the group focuses on molecular and translational metabolism, both in the context of inborn errors of metabolism and aging.  

Presentation

NAD+ as a target to promote healthy ageing. ​